Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial (Q33386511)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial |
scientific article |
Statements
1 reference
Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial (English)
1 reference
Cora N Sternberg
1 reference
Daniel P Petrylak
1 reference
Oliver Sartor
1 reference
J Alfred Witjes
1 reference
Jean-Marc Ferrero
1 reference
Jean-Christophe Eymard
1 reference
Silvia Falcon
1 reference
Fabio Calabrò
1 reference
Nicholas James
1 reference
Istvan Bodrogi
1 reference
Peter Harper
1 reference
Manfred Wirth
1 reference
William Berry
1 reference
Michael E Petrone
1 reference
Thomas J McKearn
1 reference
Mojtaba Noursalehi
1 reference
Martine George
1 reference
Marcel Rozencweig
1 reference
5 October 2009
1 reference
1 reference
27
1 reference
32
1 reference
5431-5438
1 reference
Identifiers
1 reference
1 reference